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Tissue regeneration is anorchestratedprogressionof
cells froman immature state to amature one, conven-
tionally represented as distinctive cell subsets. A
continuum of transitional cell states exists between
these discrete stages. We combine the depth of sin-
gle-cell mass cytometry and an algorithm developed
to leverage this continuumby aligning single cells of a
given lineage onto a unified trajectory that accurately
predicts the developmental path de novo. Applied to
human B cell lymphopoiesis, the algorithm (termed
Wanderlust) constructed trajectories spanning from
hematopoietic stem cells through to naive B cells.
This trajectory revealed nascent fractions of B cell
progenitors and aligned them with developmentally
cued regulatory signaling including IL-7/STAT5 and
cellular events such as immunoglobulin rearrange-
ment, highlighting checkpoints across which regula-
tory signals are rewired paralleling changes in cellular
state. This study provides a comprehensive analysis
of human B lymphopoiesis, laying a foundation to
apply this approach to other tissues and ‘‘corrupted’’
developmental processes including cancer.INTRODUCTION
Most complex organisms start as a single cell that matures
through coordinated stages of development into a diverse set
of transitional and terminal cell types, many of which have yet
to be defined. There is a continuous relationship between
maturing cell subsets: more potent cells divide and differentiate
into more functionally restricted cells. The challenge is to devise
approaches that analyze and order the cells of these complex714 Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc.tissues to reveal their developmental relationships, behavior,
and the mechanisms that govern their differentiation.
One technique that has been used to effectively determine im-
mune system hierarchies is fluorescence-activated cell sorting
(FACS) which traditionally relies on surface antigen expression
for purifying cells of a given population (Hardy et al., 1984).
One drawback of this technology is the limited number of simul-
taneously assayed markers (generally <12) which confines ex-
periments to isolating a narrow ‘‘slice’’ of the overall cellular
pool, thereby restricting the ability to characterize transitional
populations and the relationships between them. Emerging sin-
gle-cell technologies (Bendall et al., 2011; Jaitin et al., 2014),
however, can measure a large number of simultaneous features
in individual cells with unprecedented resolution. Mass cytome-
try (Bendall et al., 2011) can now quantify more than 40 features
simultaneously in thousands to millions of individual cells per
experiment. Thus, an opportunity exists to assay nearly all cell
types, from the earliest to themost mature within a given system,
and by simultaneously measuring a sufficient number of identi-
fying markers in a single sample, enable direct inference of a
continuous developmental trajectory of primary cells in situ.
A case in point is the early development of human B lympho-
cytes. Early B cells originate from the hematopoietic stem cell,
followed by a common lymphoid progenitor cell, pro-B cell,
pre-B cell, and finally an immature B cell, which migrates out
of the marrow (LeBien and Tedder, 2008). While these early
developmental hallmarks have been described in the mouse
(Rolink et al., 1999), the exact nature of cell types and timing of
critical events such as Immunoglobulin heavy chain (IgH) rear-
rangement and clonal expansion remain elusive in human B lym-
phopoiesis. As hematopoiesis is both continuous and asynchro-
nous throughout life, the full spectrum of cell types exists in a
single sample of bone marrow from a healthy individual. It was
reasoned that by combining mass cytometry with computation,
we could construct a putative B-lineage trajectory (an ordering of
cells according to their most likely developmental chronology)
representing in vivo development, from primary human bone
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Figure 1. Developmental Trajectory Detec-
tion
(A) Nonlinear relationships between developmen-
tally related cells. Markers ‘‘A’’ and ‘‘B’’ represent
sequentially expressed phenotypic epitopes on
cells in a developing system (inset). The red line
shows the expected developmental trajectory
from the earliest (cell ‘‘X’’) to the more mature cell
type (cell ‘‘Y’’). Developmentally, the distant cell
types can be close in Euclidean space.
(B) Determining the shortest path through a graph
of the data reflects temporal distance between
cells (solid red line between early [cell ‘‘X’’] and
target [cell ‘‘Y’’]) better than standard metrics (e.g.,
Euclidian norm or correlation). Short circuits
(dashed red line) impede a naive shortest path-
based algorithm.
(C) Description of the Wanderlust algorithm. The
input data are single cells in N-dimensional space
(top left). Wanderlust transforms the data into an
ensemble of graphs and selects random way-
points (purple). Each graph is independently
analyzed (single graph, red box) where a user-
defined starting cell (red) is used to calculate an
orientation trajectory. The orientation trajectory is
iteratively refined using the waypoint cells. The
final trajectory is an average over all graphs. To
examine trends, the trace of each marker can be
plotted according to trajectory position.
See also Figure S1 for evaluation of Wanderlust on
simulated data.marrow. Then, this trajectory could be used to characterize the
order of key molecular and cellular events during development.
B cell centric, 44 parameter single-cell mass cytometry data
were collected from human bone marrow, simultaneously
measuring multiple cellular features, including phenotypic pro-
teins, transcription factors, regulatory enzymes, cell-state indi-
cators, and activation of regulatory signaling molecules. Suffi-
cient cells were measured to encompass a complete spectrum
of B cell lymphopoiesis that could be reassembled into a contin-
uous progression from a single sample. Experimental design
was tailored to maximize physiologic interpretability of the data
by allowing for minimal ex vivo manipulation. The resulting
high-dimensional data were ordered using a graph-based trajec-
tory detection algorithm, Wanderlust, that orders cells to a
unified trajectory based on their maturity, thus predicting the
developmental path de novo, whichwas subsequently validated.
Wanderlust generated remarkably consistent trajectories
across multiple individuals that were largely congruent with prior
knowledge. Using the trajectory, we determined the timing and
order of key molecular and cellular events across development,
including identifying previously unrecognized subsets of B cell
progenitors that pinpoint the timing of DJ and V(D)J recombina-
tion of the IgH. Surveying the dynamic changes in cellular
expression across the Wanderlust trajectory, we identified ‘‘co-
ordination points,’’ where rewiring of the signaling network oc-
curs concurrently with the rise and fall of multiple proteins. Thesecoordination points and their characteristic signaling were
further aligned with cell-cycle status, apoptosis, and germline
IgH locus rearrangement, together forming a deeply detailed
map of human B lymphopoiesis. By exploiting the cellular het-
erogeneity of the human system while monitoring both single-
cell identity and behavior, a holistic model ordered by develop-
mental chronology was created.
RESULTS
Aligning Cells to a Developmental Trajectory
Primary human tissues are a rich source of cellular diversity as
they contain both multipotent progenitors and mature special-
ized cells. Previously, it has been shown that the transitional
co-occurrence of an extended suite of phenotypic markers,
measured simultaneously in individual cells, can be used to
roughly order cells along a developmental hierarchy (Bendall
et al., 2011; Qiu et al., 2011; Amir et al., 2013). However, previous
approaches were limited, either by false assumptions of linearity
(Figure 1A) or by stochastic partitioning of cell populations into
overly coarse clusters, losing directionality and single-cell resolu-
tion, and thus the ability to accurately order cellular relationships
(see Supplemental Information). To address these limitations, we
developed a robust algorithm that uses high-dimensional single-
cell data tomap individual cells onto a trajectory representing the
chronological order of development in fine detail.Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc. 715
Several assumptions are made regarding the data. First, the
sample includes cells representative of the entire developmental
process, including most transient and rare populations. Second,
the developmental trajectory is nonbranching: cells are placed
along a one-dimensional path. Third, changes in protein expres-
sion are gradual during development. Ordering single cells onto
a trajectory is based on continuous tracking of the progressive
rise and fall of phenotypic markers during development. This tra-
jectory provides a framework to infer the order and transition be-
tween additional key molecular and cellular events.
A fundamental challenge to constructing an accurate trajec-
tory is that the relationships between markers cannot be
assumed to be linear. Thus, determining the distance between
two individual cells using standard metrics based on marker
levels (e.g., Euclidian norm or correlation) results in poor mea-
sures of their chronological distance in development, except in
the case of very similar cells. Figure 1A demonstrates the nonlin-
earity that manifests from using only two markers; while cells X
and Y are close based on Euclidian distance, they are quite
distant in terms of developmental chronology. The complexity
of such nonlinear behavior only increases as more instances
occur in high dimensions.
A graph-based representation of the data overcomes such
problemsandhelpsconstruct adistancemetric that corresponds
to developmental chronology (Figure 1B). In the graph, each cell
is represented as a node connected to its neighbors—the cells
most similar to it—by a series of edges. Conversion into this
graph structure represents a new geometry for the data: dis-
tances between cells are defined as shortest paths on the graph
(Figure 1B), composed of steps (edges) between neighbors,
where each step traverses similar cells that are likely adjacent
in their developmental chronology.Moreover, because themodel
is based on similarity between cells, rather than relationships be-
tween parameters, it can more naturally handle the nonlinearity.
Wanderlust, a Robust Graph-Based Trajectory
Detection Algorithm
We developed Wanderlust, a graph-based trajectory detection
algorithm that receives multiparameter single-cell events as
input and maps them onto a one-dimensional developmental
trajectory (Figure 1C). Cells are ordered along a trajectory that
represents their most likely placement along a developmental
continuum. A key challenge for any such algorithm is that most
data are rife with noise from biological and technical sources.
Wanderlust determines a cell’s position based on steps between
neighboring cells, but noise accumulates with each step, so
longer paths (a series of steps) are less reliable than shorter
paths. To construct a more accurate trajectory, Wanderlust in-
corporates random waypoint cells, each of which helps refine
estimations for the positions of nearby cells. An initial estimation
of each cell’s position, including the waypoint cells, is set to its
distance from a prechosen ‘‘early cell.’’ Next, each cell’s position
is refined using its distance to nearby waypoint cells. Since the
refinement affects the positions of waypoint cells themselves,
it is repeated iteratively until each cell’s position converges
(Figure 1C).
The most harmful effect of noise is short circuits (Figure 1B):
i.e., spurious edges between developmentally distant cells that716 Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc.nevertheless have similar marker measurements. Even a single
short circuit in a graph of thousands of cells can impede con-
struction of a correct trajectory, as all shortest paths will ‘‘cut
through’’ this short circuit. Wanderlust overcomes short circuits
by building an ensemble of graphs (Figure 1C). The exact set of
neighbors varies between each graph, so any randomly occur-
ring short circuit appears in very few graphs in the ensemble. A
trajectory is constructed separately for each graph in the
ensemble and the final trajectory is found by taking the average
over the positions from all graphs, thus averaging out the influ-
ence of short circuits in the final trajectory. Full details of the
Wanderlust algorithm can be found in the Supplemental Informa-
tion section.
Wanderlust’s performance was initially evaluated using syn-
thetic data (see Supplemental Information). Wanderlust faithfully
recovered the correct trajectory (r = 0.97), even under increasing
magnitude of noise, including noise levels that exceed those
typically found in biological data (Figure S1A available online).
To emulate the short circuits that render biological data chal-
lenging, false edges were randomly added between distant
points across the entire synthetic data set following graph con-
struction. The algorithm successfully detected the solution
trajectory, even in the increasing presence of short circuits (Fig-
ure S1B). In summary, Wanderlust robustly recovered the cor-
rect trajectory from synthetic data, despite increasing noise
and short circuits, providing confidence in the trajectories it de-
rives from real data.
Constructing a Trajectory for B Cell Lymphopoiesis
B cell lymphopoiesis, a nonbranching process occurring entirely
within bone marrow, represented an ideal test case for Wander-
lust. Mass cytometry was applied to a cohort of healthy primary
human marrow aspirates (lineage-negative bone marrow mono-
nuclear cells [BMMC]) using a B cell centric marker panel (Table
S1). Forty-four markers were simultaneously measured for each
individual cell, including both phenotypic surface markers and
internal functional proteins involved in signaling, cell cycle,
apoptosis, and genome rearrangement. Both surface and intra-
cellular markers were chosen based on prior indications of their
utility in defining developmental states in B cell maturation. Not
all markers were used to construct the trajectory. Certain
markers were used to validate stages in the trajectory or to
discover new principles in the maturation process that had
been previously obscured.
BMMCwere enriched for B cells or their precursors, resulting in
200,000 cells for analysis from each individual (Experimental
Procedures). Wanderlust was applied to each marrow indepen-
dently, using a ‘‘starting position’’ of hematopoietic progenitors
(LinCD34+CD38) and the expression of 17 phenotypic markers
(Table S1) to order all cells along a one-dimensional trajectory. To
characterize marker trends over the course of this trajectory, we
used a sliding window over slices of cells, as ordered byWander-
lust; themedianmarker level, for eachmarker,wascomputedover
all cells in each window (Extended Experimental Procedures).
To evaluate the resulting trajectory, we examined the expres-
sion of canonical markers of B cell development as they align
with expected cell populations (Figure 2A). The rise and fall of
phenotypic markers along the resulting trajectory matched prior
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Figure 2. Wanderlust Confirms Known
Hallmarks of Human B Cell Development
and IsConsistent acrossHealthy Individuals
(A) The Wanderlust trajectory is fixed to an arbi-
trary scale where the most immature cells are at
0 and themostmature cells at 1. The traces (based
on median marker levels within a sliding window)
demonstrate the relative expression patterns of
CD34, CD38, CD10, CD19, IgH (s)urface, and
CD20 across development. The approximate
position of progenitors and B cell fractions is
indicated.
(B and C) Biaxial plots (B) demonstrate the
two-dimensional progression of cellular marker
expression (red arrow) across the Wanderlust
trajectory taken in segments of 0.1. (C) Distribution
of marker expression across the trajectory for
CD24, TdT, and CD10. The green line indicates the
relative standard deviation across the trajectory.
(D) Marker traces across the trajectory for four
different samples (denoted a to d) aligned using
cross-correlation. Pearson’s r > 0.9 between the
trajectories of different samples. The red box de-
marcates the expression of CD24, which bisects
the TdT expression prior to CD10 expression
across all four healthy individuals.
See also Figure S2 for traces on full marker panel
and additional robustness analysis.knowledge, starting with CD34, followed by CD38, CD10 (the
earliest canonical Pro-/Pre-B cell marker), CD19, CD20, and
ending with IgH expression, indicative of immature B cells ready
to leave the marrow. Developmental ordering was further cross-
checked using biaxial plots. Examining ten percentile slices of
cells, as ordered across the trajectory, demonstrated the ex-
pected progression (red arrows) of phenotypic markers CD34/
38, CD10/19, and CD20/IgH, respectively (Figure 2B, biaxial
plots). Together, these observations indicate that, from a starting
point of hematopoietic stem cells, the primary phenotypic land-
marks of B cell lymphopoiesis were correctly reconstructed and
ordered. This was accomplished de novo and without ex vivo
manipulation or synchronization in a single primary sample.
The Wanderlust Trajectory Is Robust across Parameter
Choice
Thealgorithm’s sensitivity to the user-defined initial cell is a crucial
feature. To evaluate this feature, initiating cells selected fromCell 157, 714–7evenly spaced points along the entire tra-
jectory were each used to seed an inde-
pendent trajectorydeterminationby theal-
gorithm. Wanderlust’s iterative approach
correctly detected the trajectory, even
when using more mature starting points
(FigureS1C). For example, using a starting
point of 0.3 on the trajectory results in a
correlation of r = 0.98 with the original tra-
jectory. With mature cells, the trajectory
reverses, but remains congruent, with a
correlation of r = 0.98 between the for-
ward and reverse trajectory (Figure S1C).To test the robustness of the algorithm to the selection of
phenotypic features used to map the trajectory, Wanderlust
was run removing one marker at a time, and the correlation
with the original trajectory was assessed. Exclusion of any one
individual marker had little effect on the overall trajectory as evi-
denced by the strong correlation (r > 0.97) with the original
model, except HLA-DR (Figure S2A). Wanderlust was then run
removing all of six key B cell markers (CD19, CD20, IgM-i,
IgM-s, CD79b, and CD10), and the correlation with the original
trajectory remained (r > 0.95, Figure S2B). Thus even without
canonical markers, Wanderlust was able to correctly order the
events and phenotypic progression of B cell lymphopoiesis.
Note that only three of the seven markers in this trace were actu-
ally used for the Wanderlust analysis (Figures S2C and S2D).
Additionally, we tested the algorithm’s robustness by varying
all free parameters. We compared trajectories generated inde-
pendently over a wide range of parameter values to our original
model, constructed using default parameters, and found a25, April 24, 2014 ª2014 Elsevier Inc. 717
correlation of (r > 0.99) between trajectories (See Supplemental
Information). In conclusion, the Wanderlust algorithm constructs
a remarkably consistent trajectory and is robust to variation in
the parameters used for its construction.
Importantly, not only do the median marker levels follow ex-
pected trends over the trajectory, variation in marker expression
within each window was remarkably low (Figures 2C and S2E).
This tightness is especially apparent with TdT, which was not
used as input to the algorithm. At any given point, the distribution
of B cell centric epitopes was tight around themedian, indicating
the algorithm’s ability to leverage multidimensional information
to create a highly organized trajectory of cellular development
in silico. Thus, the quality of the trajectory is demonstrated by
its robustness and marker tightness.
The Trajectory Is Consistent across Individuals
Having demonstrated Wanderlust’s robustness when applied to
a single healthy bone marrow sample, we investigated whether
the trajectory of human B cell development is consistent across
independent human samples. Altered proportions of cell sub-
types due to outside factors (genetics, exposure to pathogens,
etc.) could lead to scaling discrepancies between the output tra-
jectories, yet we expected to see the general shape, order, and
coexpression of given markers maintained. To account for the
scaling variations expected due to subpopulation frequency dif-
ferences, we used cross-correlation (see Experimental Proce-
dures) to compare the trajectories of four independent bone
marrow samples (using the same experimental procedures).
The four trajectories were completely overlaid (Figures 2D and
S2D), demonstrating that Wanderlust consistently recapitulates
the developmental trajectory across independent samples
despite distinct genotypes and environmental backgrounds.
In addition, we observed qualitative agreement on the order of
molecular events. Focusing on the less-characterized emerging
B cell populations at the beginning of the trajectory, Wanderlust
revealed that CD24 consistently bisected the wave of terminal
deoxynucleotidyl transferase (TdT)—an enzyme that partici-
pates in rearrangement of the IgH locus (Figure 2D). Both
CD24 and TdT were reliably expressed earlier than expected,
before the rise of CD10, a canonical surface marker believed
to be the earliest identifying surface marker of emerging human
B cells committed to the lineage.
Ordering of Emerging B Cell Precursors
The Wanderlust trajectory guided the identification of distinct,
early populations, and determined their relative ordering across
development. The expression of both TdT and CD24 increased
prior to the expression of any canonical B cell surface markers
(i.e., CD10 or CD19) in every bone marrow sample examined
(Figure 2D). Given TdT’s defining role in mammalian B cell emer-
gence, we hypothesized that TdT, in combination with CD24 and
other progenitor markers, could serve as a novel set of identifiers
to dissect early populations of human B cells in the marrow. We
used Wanderlust to guide the selection of a series of biaxial
gates based on CD34, CD38, CD24, and TdT, revealing four
distinct populations of cells (Figure 3A). According to Wander-
lust, these were early cellular fractions sequentially occupying
populations labeled II-V (Figure 3A, S3A). Additional phenotypic718 Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc.markers, including l5 (CD179b), vPreB, CD10 and intracellular
IgH protein (Figure 3B), were used to support the determined
progression of these populations and their identity as definitive
early B cells. Thus, the Wanderlust trajectory of these popula-
tions (II-V) is confirmed by protein coexpression patterns typical
of B-lineage development.
VH(D)JH Recombination Confirms Ordering of Novel
Early Human B Cell Populations
To independently confirm the developmental ordering of the
hypothesized early B cell fractions, we used the rearrangement
of the germline IgH locus, the molecular target of TdT, as a mea-
sure of developmental stage and B cell identity. A quantitative
polymerase chain reaction (qPCR) assay was developed to
quantify the relative proportions of DJH and VH(D)JH arranged
cells and validated by assaying mixtures of cells containing
known proportions of mature (fully rearranged) B cells (Figures
S3B–S3C). FACS was then used to isolate populations II–V (Fig-
ure S3D) from BMMC preparations of two additional subjects.
Genomic DNAwas extracted from each fraction, and the relative
IgH rearrangement status of each fraction was quantified using
the qPCR assay.
As anticipated, relative to population II, there was a progres-
sive rearrangement of the IgH locus toward population V. Most
cells had detectable DJH rearrangement upon reaching popula-
tion IV and VH(D)JH rearrangement upon reaching population V
(Figures 3C and 3D). This was consistent with the observation
that virtually all cells in fraction V displayed intracellular expres-
sion of IgH protein (Figure 3B, asterisk [*]). Establishing the pro-
gressive rearrangement of IgH in these populations confirmed
that the Wanderlust trajectory not only facilitated the identifica-
tion of the earliest human B lymphocytes, but also accurately
ordered their developmental timing, all from the analysis of a sin-
gle human marrow, without synchronization or manipulation.
This ability to identify and order cells was particularly notable
given the sparsity of cells in these early fractions. Figure 3E high-
lights the rarity of these early B cell populations relative to total
BMMCs. In particular, population III comprised only 0.007% of
total BMMCs. The fact that population III occurs prior to CD19
expression (Figures 2A–2B), in combination with inconsistent
expression of CD10 (Figure 3B), suggests why these populations
had not been described previously.
pSTAT5 Response to IL-7 Is Confined to Rare B Cell
Precursors
Mass cytometry allows simultaneous measurement of surface
markers, as well as internal functional proteins and their modifi-
cations, in the same cells. To functionally characterize early B
cells and how they respond to stimuli, data were collected
following multiple cellular signaling perturbations, including the
cytokine IL-7 (Table S2). The activation of STAT5 by IL-7 via its
phosphorylation site has a critical regulatory role in mouse lym-
phopoiesis (Corfe and Paige, 2012): disruption of this pathway
results in arrest of B cell maturation at the pro-B cell stage (Malin
et al., 2010). However, in human, the precise developmental
timing of this pathway and its regulatory role remain unclear.
Investigation of signaling response to IL-7 across the four early
B cell populations II–V revealed that cells within population III
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Figure 3. Wanderlust Uncovers Rare B Cell Progenitors prior to the Expression of CD10 or CD19
(A) Wanderlust trace showing the expression of CD24, CD34, CD38, and TdT (upper left). Density plots of four distinct TdT and CD24 populations defined within
the CD34+CD38+ fraction (right). A histogram overlay of the Wanderlust values for cells contained in population I-V (dark blue boxes). The median Wanderlust
values are indicated.
(B) Expression of the surrogate light chain of the pre-B cell receptor, l5, and VpreB (top), and CD10 and IgH (i)ntracellular (bottom) across populations I though V.
Asterisk (*) denotes the uniform expression of IgHi in population V.
(C and D) Relative to population II, the amount of (C) IgH DJ and (D) IgH V(D)J rearrangement by qPCR of genomic DNA from prospectively isolated cells from
populations II-V. Triplicate analysis of two biological replicates. Error bars are standard deviation. Asterisk (*) denotes uniform IgHi expression implying complete
IgH V(D)J rearrangement.
(E) Pie charts summarizing the cellular contribution of human BMMCs. The purple pie denotes CD34+CD38+ cells. Percentages are relative to all BMMCs. RBC,
red blood cell; PMN, polymorphonuclear cell; MNC, mononuclear cell.
See also Figure S3 for supporting data.displayed an almost exclusive5-fold induction of STAT5 phos-
phorylation versus basal (Figure 4A)—a striking observation
considering population III represents seven in 10,000 cells in
the marrow (Figure 3E). Moreover, this pinpointed response
was consistent across seven distinct marrows from independent
human subjects. We note that pSTAT5 and other functional
markers were not used to construct the Wanderlust trajectory
and therefore this pattern of pSTAT5 induction was not enforced
by the algorithm, but rather was revealed due to its precise
phenotypic ordering of cells.
STAT5 Network Rewiring Occurs during
Immunoglobulin Rearrangement
Since the IL-7/STAT5 response was limited to a specific fraction,
STAT5 regulation was further characterized relative to adjacent
cell fractions across the developmental progression. We used
the JAK inhibitor Tofacitinib, combined with IL-7 stimulation, to
confirm a Janus kinase mediated mechanism of STAT5 control(Johnson et al., 2005). As expected, within population III,
STAT5 activation was attenuated by treatment with Tofacitinib,
indicating a JAK mediated mechanism (Figures 4B and S4A).
Populations III’s induction of pSTAT5 coincides with the cells
gaining expression of the IL-7 receptor (CD127), where all
CD127-positive cells of population III strongly induce pSTAT5
in response to IL-7 (Figure S4B). IL-7 receptor levels continue
to rise in populations IV and V (Figure 4C), yet ex vivo IL-7 stim-
ulation no longer induces pSTAT5 in these later populations (Fig-
ure S4B). However, cells occupying population IV display a
higher basal level of pSTAT5 (Figure 4C). To test if pSTAT5 levels
are saturated in later populations, the pan tyrosine phosphatase
inhibitor pervanadate (PVO) was tested. In the presence of
PVO, the levels of pSTAT5 rose in all CD34+ progenitor B cell
fractions, across biological replicates (Figure 4B and S4A). Addi-
tionally, cells in populations III and partially IV yielded a similar
STAT5 phosphorylation pattern in response to thymic stromal
lymphoprotein (TSLP) (Figures 4B and S4A), a ligand that sharesCell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc. 719
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Figure 4. Regulatory Signaling Rewires
across Development
(A) Compared to basal control, the IL-7 induction
of pSTAT5 in populations I through V. Population III
(CD34+CD38+TdT+) had consistently the largest
induction across seven replicate BM. Induction is
arcsinh difference versus basal, scaled individu-
ally. Maximum differences were 0.8, 2.2, 1.7, 1.3,
0.3, 0.8, and 1.8 for A to G, respectively.
(B) The effect of TSLP, tofacitinib (JAK1/3i), and
pervanadate (PVO) on induction of pSTAT5 across
populations I to V in the same individual versus the
basal. The maximum difference is 1.3.
(C) Early Wanderlust trace (trajectory 0–0.5)
showing expression of IL-7ra (CD127), TdT, and
IgHi. The green heat bar indicates relative pSTAT5
phosphorylation in the basal sample. Relative po-
sitions of populations I to V and IgH V(D)J re-
arrangement are indicated.
(D) Network rewiring between population III and IV.
The schematics show proposed regulatory net-
works of pSTAT5; population III activates in a
ligand and JAK-dependent manner whereas
population IV becomes ligand independent, but
maintains a high pSTAT5 level in the absence of
stimulation. See also Figure S4 and Table S2 for
additional perturbations and full distributions rep-
resenting the IL-7 perturbation.the IL-7ra chain (CD127) and activates STAT5 (Kang and Der,
2004).
Together these observations illustrate a STAT5 network
rewiring over the development of B cell precursors (Figure 4D).
STAT5 phosphorylation is initially dependent upon an exoge-
nous ligand (i.e., IL-7, TSLP or others) in a JAK-mediated mech-
anism (population III). Then, despite continued expression of the
IL-7 receptor, STAT5 phosphorylation becomes ligand indepen-
dent (population IV–V), yet remains basally high relative to devel-
opmentally adjacent cells.
Previous studies in mouse have implicated the IL-7-depen-
dent STAT5 induction in the initiation of genomic rearrangement
(Malin et al., 2010). The peak expression of TdT (Figure 4C) indi-
cated that cells in population IV are actively rearranging the IgH
locus of the immunoglobulin gene (Figures 3C and 3D). There-
fore, the switch in regulation of STAT5 activation overlaps with
germline gene rearrangement, a cell state in which successful
outcome requires careful monitoring by the cell. Thus, when cells
were organized into a progression, we observed the coordinated
rewiring of the regulatory signaling network in the rare, early B
cell populations (Figure 4D).
Derivative Analysis of the Trajectory Reveals
Coordination Points in B Cell Development
The coordinated expression of phenotypic markers coupled with
rewiring of regulatory signaling suggested that these events coa-
lesced around developmental checkpoints controlling the pro-
gression of B cell lymphopoiesis. Because this highly multi-
plexed data set, combined with the developmental ordering
revealed by Wanderlust, allows examination of the concurrent
timing of protein expression across B cell development, we
used derivative analysis to determine the rates by which given720 Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc.markers changed at each point along the trajectory. The first de-
rivative for each marker along the Wanderlust trajectory was
approximated using a sliding window (Figure 5A).
The derivatives were examined to see if multiple phenotypic
features changed in a coordinated fashion. Clustering the pa-
rameters based on the absolute value of their derivative across
the trajectory uncovered several striking coordination points
where the changes in expression of multiple proteins coalesced
across B cell development (Figure 5B). At least four major coor-
dination points were identified across the trajectory (Figure 5B,
dashed boxes) and were consistent across samples from inde-
pendent human subjects (Figure S5). The first (Figures 5B and
5C, red) coincides with population III, the ligand-dependent
pSTAT5 cells (Figure 4), representing cells at the early pro-B
cell stage of development just prior to IgH locus rearrangement.
The second (Figures 5B and 5D, blue) is consistent with cells that
are passing through the pre-B cell stage and are preparing to re-
arrange the light-chain locus of the immunoglobulin (Cobaleda
and Sa´nchez-Garcı´a, 2009).
Light-chain rearrangement is crucial to the latter two coordina-
tion points. The first of these (Figures 5B and 5E, purple) coin-
cides with kappa light-chain protein expression, which mirrors
the trajectory of CD20, signifying that the expression of CD20
occurs in concert with BCR light-chain rearrangement and
expression. Cells that do not successfully express kappa switch
to lambda light chain, both consistent with the known biology
and correctly ordered by Wanderlust (Figure 5B, asterisk [*],
and E). The last coordination point (Figures 5B and 5F, black)
cements the emerging cells as naive, immature B cells preparing
to enter peripheral lymphoid organs.
In summary, Wanderlust successfully organized a dynamically
asynchronous cellular system, providing a holistic view of the
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Figure 5. Coordination of Protein Expression across B Cell Development
(A) The first derivative was calculated in windows across the trajectory for each marker. These values are expressed as a heat map with red indicating a positive
slope (increasing expression) and blue indicating a negative slope (decreasing expression).
(B) Heat map summary of the first derivative analysis, rows aremarkers and columns the progression of the trajectory. Markers were hierarchically clustered using
absolute values of the first derivative. Asterisk (*) indicates decline in kappa light-chain expression coincident with increase in lambda light-chain expression.
Coordination points: (C) at 0.25 Wanderlust (red dashed line and box) rise in VpreB, l5, TdT, CD10, and CD24 and fall in CD117 expression; (D) 0.3–0.4 (blue
dashed line and box) drop in CD34 expression and increases in CD19, CD20, IgHi, and Pax5; (E) 0.6 (purple dashed line and box) showing increases in CD20,
kappa, and lambda light-chain protein expression. (F)0.8 (black dashed line and box) with drop in CD38 expression and increases in CD40, IgD, and CD22. See
also Figure S5 for additional replicates.coordination of a complex system, even for transient and rare
cell types. Derivative analysis reveals a closely coordinated se-
ries of regulatory and cellular events, suggesting coordination
points that might act as checkpoints between shifts in cellular
states and fate determinations.
Coordination Points Reveal a Checkpoint for B Cell
Developmental Progression
Using Wanderlust to overlay simultaneously measured indica-
tors of cell proliferation (Ki67) and apoptosis (cleaved poly ADP
ribose polymerase–cPARP) revealed a further level of functional
coordination across nascent human B cell populations (Fig-
ure 6A). The first coordination point (Figure 6A, red arrow) marks
a transition from a state of high to low proliferation, as assessed
by decreasing Ki67 expression (Figure 6A, background shade).
This drop in proliferation leads directly into population IV (Fig-
ure 6A), signifying the transition into pro-B cells, suggesting a
checkpoint that has never been clearly demonstrated in the
human.
As the cells pass through the second coordination point, which
occurs after the IgH locus has been completely rearranged, Ki67
levels show that the cells re-enter a state of proliferation, ex-panding the pool of pre-B cells, which have productively formed
an IgH (Figure 6A, blue arrow). Just preceding this pre-B cell
expansion there is a discrete spike in cell death, indicated by
a surge in single cells with higher cPARP (Figure 6A, yellow
line), consistent with cells that could not form a productive IgH
rearrangement and thus were unable to pass through this
checkpoint.
In concert with expression of VpreB and l5, the newly ex-
pressed IgH now composes a complete pre-B cell receptor
(preBCR). Mapping cells following B cell receptor crosslinking
onto Wanderlust demonstrates that precisely paralleling the sur-
face expression of the IgH (IgHs), cells are able to induce
massive phospholipase C (PLC) gamma 2 phosphorylation (Fig-
ure 6B, red) as compared to the basal state (Figure 6B, black).
Thus, with pre-BCR on the surface of the cells, they have yet
again rewired their regulatory signaling and have become
responsive to receptor crosslinking (Figure 6B).
Ex Vivo Differentiation Assay Confirms Pro-B Cell
Checkpoint
To determine the role these checkpoints play in a cell’s develop-
mental progression, the earliest pro-B cell checkpoint wasCell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc. 721
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Figure 6. Regulatory Signaling Influences
Cell Fate Decisions in Developing B Cells
(A) Wanderlust traces of VpreB, l5, IgHi, and
cleaved PARP across the early trajectory (0.1–0.6).
The background is shaded for Ki67 (proliferative
antigen) expression. Indicated are the relative
positions of population II to V. The red and blue
arrows indicate putative timing of pro- and pre-B
cell coordination points, respectively.
(B) Wanderlust traces across the late trajectory
(0.3–0.9) showing IgH (i)ntracellular and (s)urface
expression with the basal and receptor cross-
linked levels of pPLCY2, an intermediary of B cell
receptor signaling. pPLCY2 induction in response
to crosslink shown in yellow.
(C) Using two human BM samples, B cell differ-
entiation cocultures were performed, following
lineage depletion, for 6 weeks on an OP-9 stromal
layer in the presence or absence of inhibitors.
After, cells were analyzed by flow cytometry for the
frequencies of populations II through IV.
(D) Frequency of populations II through IV, as a
proportion of CD34+CD38+ cells, after 6 weeks
of culture in the indicated condition. Each treat-
ment is normalized to the DMSO control for that
population. Two biological replicates analyzed
in quadruplicate cultures for each condition. Error bars are standard deviation. A two-tailed t test was performed to determine statistical significance
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S6 and Table S4 for supporting data.interrogated using an ex vivo differentiation assay (Figure 6C,
Tables S3 and S4). The rewiring of STAT5 regulation across frac-
tions II to IV (Figure 4) suggests that a blockade of STAT5 phos-
phorylation could alter the progression of cells through the pro-B
checkpoint proposed here. To test this, Lin human BMMCs
from two donorswere differentiated onOP-9 stromal cell feeders
for 6 weeks (Sanz et al., 2010), after which the relative propor-
tions of fractions II through IV were assessed.
Both JAK inhibitors used, Ruxolitinib (JAK1/2 inhibitor) and
Tofacitinib (JAK1/3 inhibitor), restricted progression of cells
from population II through to population IV (Figure 6D), signifi-
cantly decreasing the frequency of cells in population IV, relative
to a DMSO control. At the same time, there was a significant
accumulation of cells in population II. The P38 inhibitor, did not
have a significant influence on the allocation of cells across the
three fractions, though it did promote significant, albeit compart-
ment independent, cellular expansion (Figure S6B). Collectively,
these ex vivo culture assays imply that STAT5 promotes the
developmental progression of early B cell precursors, where
the ligand-dependent phosphorylation in population III likely
represents a critical (pro-B cell) transition point for initiating
IgH V(D)J rearrangement and progression to later stages of
maturity.
DISCUSSION
By leveraging the massively multiplexed, single-cell analysis of a
complex primary sample, algorithmic ordering of cellular pro-
cesses can detect the underlying temporal element in the system
and be used for novel biological inquiries. The Wanderlust algo-
rithm described here is resilient to noise, consistent between
samples, and scalable to up to tens of millions of cells. It extracts722 Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc.a trajectory from a snapshot of the system rather than from time-
series data and only requires an approximate starting point as
prior information. The Wanderlust trajectory is continuous; in
addition tomapping stable cell states, it alsoprovides information
about the transitions between states. The combination of these
characteristics makes this an ideal approach for the exploration
of any system undergoing a continuous developmental process.
As single-cell measurements amass due to new technologies
such as mass cytometry and single-cell RNA-seq, researchers
are faced with the novel challenge of organizing this volume of
data. The solution most commonly used is clustering, but by
averaging cells into groups, this approach loses the richness of
single-cell resolution. Using the graph approach proposed
here, rather than assigning single cells to a group of similar cells,
each cell is mapped to a unique position in a graph structure that
can be easily navigated. This structure affords many of the ad-
vantages of clusteringwhile preservingmuch of the cell’s individ-
ual information. This graph-based representation of single-cell
data can be adapted to a wide range of additional applications.
Wanderlust determined the developmental trajectory of
human B cell emergence in bone marrow by simultaneously
examining the features of this primary tissue from progenitor to
maturity, requiring no cellular synchronization, purification, or
manipulation. The trajectory is consistent with the traditional un-
derstanding of this process. Furthermore, Wanderlust provides a
quantitative, high-resolution ordering of surface marker expres-
sion, signaling, and recombination events, including markers
whose timing and relevance were previously unappreciated.
The determined trajectory unifies virtually all relevant cellular fea-
tures and regulatory behaviors of early B cell development in the
human with discrete cell subsets that can now be demarcated
using conventional cytometric methods (Figure 3).
Figure 7. Summary of Phenotypic Marker
Expression, Regulatory Signaling, and IgH
Recombination Status and Proposed Pro-
and Pre-B Cell Checkpoints Aligned to Re-
ported Populations across Human B Cell
Development as Ordered by the Wanderlust
Trajectory
Under ‘‘Definition’’ (top) the expected marker
localization and expression is listed for subse-
quent cytometric characterization. ‘‘Bold type’’
markers are the minimum required to positively
select cells by cytometric analysis. ‘‘Regular type’’
markers are uniformly expressed on the surface.
‘‘Italic type’’ markers are intracellularly expressed.
Markers in parentheses ‘‘()’’ are only partially ex-
pressed on that fraction. Red and blue bars indi-
cate the pro- and pre- B cell coordination points,
respectively. For regulatory signaling and IgH
status (bottom), the gray bars indicate the devel-
opmental regions where cells are prone to the lis-
ted behaviors. See also Figure S7 for additional
replicates.A Unifying Model of Mammalian B Cell Development
Because it is difficult to obtain and experimentally manipulate
human bone marrow, the understanding of mammalian B cell
development comes mostly from murine systems. The
Wanderlust trajectory identified a precise ordering of key
events and explicitly pinpointed the developmental hallmarks
of B cell development, previously assumed to exist based on
the murine system, in the human. A more precise overview
of human B cell development in the bone marrow is now
made possible by aligning phenotype with regulatory signaling
and key developmental events such as immunoglobulin rear-
rangements (Figure 7). Moreover, the progression identified
by Wanderlust is maintained across all donor bone marrow
specimens examined, such that the developmental timing of
key coordination points ordered by the Wanderlust trajectoryCell 157, 714–7are consistent across independent mar-
rows and analyses (Figure S7).
In addition, the Wanderlust trajectory
facilitated an in-depth examination of
rare and transient early stages of B cell
development: previously unrealized popu-
lations of B cell progenitors based on the
combined expression of CD34, CD38,
CD24, and TdT. Notably, the earliest of
these B cell precursors expressed neither
CD10 nor CD19, the earliest markers
conventionally used in human B cell iden-
tification (Cobaleda and Sa´nchez-Garcı´a,
2009). Previous experimental studies of
early B cells, which relied on identification
based on expression of CD10 or CD19,
would have entirely excluded the earlier
fraction of B cells highlighted here.
Moreover, the overlay of multiple
markers onto a single trajectory offered
a holistic picture of the coordination of acomplex system, even for transient and rare cell types; in partic-
ular, identifying regulatory signal rewiring of STAT5 regulation
across populations III through V. Remarkably, IL-7 induced acti-
vation of STAT5 was a limited regulatory state, only active in a
rare population of the cells. While population III comprises only
0.007% of the BMMCs, the results demonstrated that it serves
as a checkpoint to ensure successful initiation of IgH rearrange-
ment. Through this lens, coordination points appear as a hall-
mark of developmental progression.
A Discrete Versus Continuous Concept of Cellular
Development
Much effort has been devoted to the taxonomic characterization
of cellular populations across development in virtually all tissues,
with new cell subsets constantly being described based on25, April 24, 2014 ª2014 Elsevier Inc. 723
increasingly complex patterns of expression. Although it is easy
to conceptualize this process as a series of discrete steps, in re-
ality, it is continuous and characterized by transitional stages. In
our approach, the trajectory captures expression as trends:
markers rise and fall in patterns that correspond to the cell’s
behavior, capturing transitional behavior. Applying Wanderlust
to high-dimensional single-cell data from a primary human tissue
determined a developmental ordering (trajectory) of cells without
any time-point experiments or genetic manipulations. Further-
more, as seen in Figure S1, the algorithm was able to begin
from a late cell and map the trajectory from a known finale
back to its beginning. This variation is relevant in the context of
nonhematopoietic development, where the stem cells are not
known but the mature cells are plentiful and easily identified,
such as in mesenchymal development.
A Foundation upon which to Understand Disease
Many human diseases can be considered corruptions of normal
development. Indeed, pathologic examination of tissues often
reports findings as the degree of divergence from normal tissue
architecture. However, our understanding of the underpinnings
of a disease is only as good as our understanding of the normal,
healthy condition. Wanderlust provides the ability to infer regula-
tory events across the healthy developmental trajectory, so it is
now possible to use the precise foundation of healthy tissue
ordering to further understand corrupted developmental disease
processes.
In the case of lymphopoiesis, as demonstrated here, the iden-
tification of coordination points across development coupled to
critical regulatory signaling that influence cell fate decisions
(including survival and proliferation), highlights specific develop-
mental periods of risk for malignant transformation. Understand-
ing the critical network configurations that surround these transi-
tions may provide important insight into disease, especially
when a developmental state may serve as an additional diag-
nostic or classification metric.
There are several possible extensions to the concepts pre-
sented here. Wanderlust assumes that the developmental pro-
cess is composed of a series of consecutive stages, with no
branching. Incorporation of a more sophisticated model that
allows forbranchingwill enable theanalysisofmore complex sys-
tems, such as the complete immune system. Given its flexibility
andminimal experimental requirements, this study lays the foun-
dation for applying these methods to other tissue types and cor-
rupted developmental processes, such as cancer, in the future.
EXPERIMENTAL PROCEDURES
Mass Cytometry Analysis
Processing of primary human bone marrow and mass cytometry analysis
including data preprocessing is as previously described (Bendall et al., 2011;
Fienberg et al., 2012; Finck et al., 2013; Kotecha et al., 2010; Amir et al., 2013).
Extended description of these methods can be found in the Supplemental
Information.
Analysis of Primary Human B Cells
Lin BMMCs were stained for CD34, CD38, TdT, and CD24 and populations II
through V were collected on a FACS Aria (BD Bioscience). Unamplified
genomic DNA from the sorted cell populations was assessed for the level of724 Cell 157, 714–725, April 24, 2014 ª2014 Elsevier Inc.IgH (D)J and V(D)J rearrangement using a qPCR approach adapted from
adapted from Van Dongen et al. (van Dongen et al., 2003). OP-9 progenitor
cell cocultures for B cell specification were performed as previously described
(Sanz et al., 2010). Extended description of these methods can be found in the
Supplemental Information.
The Wanderlust Algorithm
Input and Initialization
The Wanderlust trajectory detection algorithm receives as input the high-
dimensional sample data and a user-defined initial cell (for example, a stem
cell), referred to here as the ‘‘early’’ cell. The output is a continuous trajectory
score for each cell that provides the cell’s temporal positioning across devel-
opment; undifferentiated cells have low scores whereasmature cells have high
scores. Wanderlust is composed of two steps: initialization and trajectory
calculation, which is performed iteratively, see outline below. Please refer to
the Extended Experimental Procedures for a full and detailed description of
the Wanderlust algorithm.
Wanderlust Outline Description
Wanderlust receives as input the single-cell measurements and a user-defined
early cell. The algorithm begins with a two-step initialization step (Figure 1C,
top left). First, a set of cells is randomly chosen as waypoints. Then, the data
are transformed into a randomly generated ensemble of graphs. The algorithm
proceeds by calculating a trajectory separately in each graph. For each cell
(called a target), its position along the trajectory is first set to the shortest-
path distance from the early cell. The target’s position is refined according
to the shortest-path distance from each waypoint using a weighted average.
Waypoints closer to the target contribute more to its location as they are
less susceptible to the noise inherent in the shortest-path distance. However,
the waypoints are themselves targets. Therefore, their position will change
following this same refinement step. Since cell positions depend on waypoint
positions, the shift in waypoints might change the newly calculated positions.
Therefore, the refinement step is repeated with the newwaypoint positions un-
til the positions of all cells converge. Once the trajectory calculation step com-
pletes in all of the graphs, the output trajectory is set to the average over all
graph trajectories.
Simulated Data
We applied Wanderlust to a series of simulated data sets. Each data set
included the same curved, one-dimensional simulated trajectory that was
embedded in three dimensions. The simulated trajectory was generated by
starting at position (1, 1, 1) and randomly traversing the space for 10,000 steps.
After each step the current position was added to the trajectory as a point.
Seven additional dimensions of normally-distributed noise were added to
each data set. Themagnitude of the noise dimensions (defined as the standard
deviation divided by the range of the solution trajectory) varied between data
sets. Additionally, some data sets included short circuits; the number of short
circuits varied between data sets, and their distances were exponentially
distributed with mean again varying between data sets. Full details are avail-
able in the Extended Experimental Procedures.
Wanderlust Analysis
Wanderlust was run on 17 phenotypic markers in each sample using the
following parameters: nl = 20, dist = angular distance, ng = 20, k = 5, l =
30. The early cell was chosen as the cell expressing the highest level of
CD34. The output trajectory was normalized to the [0, 1] range by subtracting
the 5th percentile and dividing by the value of the 95th percentile minus the
5th percentile. We defined the trace of each marker as the median marker in-
tensity in overlapping windows across the trajectory. One hundred windows
were uniformly distributed across the [0, 1] range. Each window included all
cells whose trajectory score was within ± 0.08 of the center of the window.
Wanderlust Cross-Correlation between Individuals
Given a marker, for each sample, we calculated the cross-correlation between
the trace of the marker in the sample and its trace in an arbitrarily chosen sam-
ple (sample A). The trajectory was shifted such that the mean of all cross-
correlations was maximized.
Wanderlust Derivative Analysis
Given the trace of a marker tm over the Wanderlust trajectory w, we calculated
an approximation of the derivative of the trace at a given point p using:
t
0
mðpÞ=
tmðp+ 1Þ  tmðp 1Þ
wp+ 1 wp1
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2014.04.005.
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